Camurus AB

Industry · 8 registered clinical trials.

Status	Trial	Phase	Started
Active Not Recruiting	A Trial to Assess the Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With PLD Polycystic Liver Disease	Phase 2 / Phase 3	2022-06-28
Active Not Recruiting	A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With GEP-NET Gastro-enteropancreatic Neuroendocrine Tumor	Phase 3	2021-10-22
Completed	A Trial to Assess the Long-term Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly Acromegaly	Phase 3	2019-10-10
Completed	A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly Acromegaly	Phase 3	2019-08-19
Completed	Phase II Study of Subcutaneous Inj. Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours Acromegaly, Neuroendocrine Tumors	Phase 2	2015-01-01
Completed	Phase II Study of Subcutaneous Injection Depot of Leuprolide Acetate in Patient With Prostate Cancer Prostate Cancer	Phase 2	2014-09-01
Completed	A Comparative Investigation of Standard Of Care (SOC) and Episil® in Combination Versus SOC Alone on Oral Muco Oral Mucositis	N/A	2013-02-01
Completed	Effects of Mucoprotective Product on Xerostomia Xerostomia	Phase 4	2011-02-01